All four recipients funded under the Telehealth Research and Innovation for Veterans with Cancer (THRIVE) grant, including NYU Grossman School of Medicine, participate in a pragmatic trial. THRIVE will collaborate with the VA National TeleOncology Program (VA NTOP) as it rolls out telehealth care for cancer in more than 100 VA facilities to conduct a comprehensive evaluation of the multilevel virtual oncology program, focusing on engagement with telehealth and reducing healthcare disparities.

Aims for the THRIVE Pragmatic Trial include the following:

• evaluate the effect of a comprehensive multilevel virtual oncology program to promote telehealth engagement on stakeholder cancer care experience across social determinants of telehealth (SDTH)
• evaluate the effect of a comprehensive, multilevel virtual oncology program on quality of cancer care in veterans diagnosed with lung, colorectal, prostate, and breast cancer across SDTH
• determine the impact and cost of a comprehensive multilevel teleoncology program

By analyzing the rollout of its state-of-the-art oncologic care across such a large set of sites, THRIVE will be able to assess the impact of the program while helping to adjust for measured and unmeasured confounding.